Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
"Lysosomal glycogen storage disease with normal acid maltase" which was originally described by Danon et al., is characterized clinically by cardiomyopathy, myopathy and variable mental retardation. The pathological hallmark of the disease is intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells. Sarcolemmal proteins and basal lamina are associated with the vacuolar membranes. Here we report ten unrelated patients, including one of the patients from the original case report, who have primary deficiencies of LAMP-2, a principal lysosomal membrane protein. From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease. To our knowledge this is the first example of human cardiopathy-myopathy that is caused by mutations in a lysosomal structural protein rather than an enzymatic protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Cardiomyopathies | Whole‐body deletion of Lamp2 | Accelerated development of a vacuolar cardioskeletal myopathy similar to Danon disease | Nishino et al (2000), Tanaka et al (2000) |”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al (2000)
In the citing paper
“In addition, broad‐spectrum autophagic defects tied to the systemic ablation of LAMP2 (causing Danon disease) account for the early development of hypertrophic cardiomyopathy (Nishino et al, 2000; Tanaka et al, 2000).”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al, 2000
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
An association between migraine and cutaneous allodynia
Burstein, R., Yarnitsky, D., Goor‐Aryeh, I., Ransil, B. J., & Bajwa, Z. H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<684::aid-ana27>3.0.co;2-o · Cited by 1,025
Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.-L., Hartmann, D., Lüllmann-Rauch, R., Janssen, P. M. L., Blanz, J., von Figura, K., & Saftig, P. (2000) · Nature · doi:10.1038/35022595 · Cited by 925 · cited 1×
“From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon diseas”
ResultA novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
Town, M., Jean, G., Cherqui, S., Attard, M., Forestier, L., Whitmore, S. A., Callen, D. F., Gribouval, O., Broyer, M., Bates, G. P., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-319 · Cited by 639 · cited 1×
“Our results, together with the recent identification of mutations in the lysosomal proteins cystinosin and sialin that cause nephropathic cystinosi”
ResultLysosomal glycogen storage disease with normal acid maltase
Danon, M. J., Oh, S. J., DiMauro, S., Manaligod, J. R., Eastwood, A., Naidu, S., & Schliselfeld, L. H. (1981) · Neurology · doi:10.1212/wnl.31.1.51 · Cited by 405 · cited 4×
“In 1981, Danon et al.1 reported two boys with the clinical triad of cardiomyopathy, myopathy and mental retardation.”
BackgroundInfluentialSelf-citationSaitoh, O., Wang, W. C., Lotan, R., & Fukuda, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42823-2 · Cited by 308
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases
Verheijen, F. W., Verbeek, E., Aula, N., Beerens, C. E. M. T., Havelaar, A. C., Joosse, M., Peltonen, L., Aula, P., Galjaard, H., van der Spek, P. J., et al. (1999) · Nature Genetics · doi:10.1038/70585 · Cited by 293
Lysosomes, a meeting point of proteins, chaperones, and proteases
Cuervo, A. M., & Dice, J. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050185 · Cited by 201 · cited 1×
“Alternatively, the unusual muscle pathology in DD might result from impaired lysosomal protein processing because the cytoplasmic tail of LAMP-2 functions as a receptor for the uptake of certain proteins into lysosome in association with the relative molecular mass ( M r ) 73,000 heat shock cognate protei”
BackgroundPattern of malformations in the axial skeleton in human triploid fetuses
Kjær, I., Keeling, J. W., Smith, N. M., & Hansen, B. F. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971017)72:2<135::aid-ajmg3>3.0.co;2-u · Cited by 120
Konecki, D. S., Foetisch, K., Zimmer, K.-P., Schlotter, M., & Konecki, U. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2528 · Cited by 116 · cited 1×
“Human exon 9 exists in two forms, 9a and 9b, which are alternatively spliced and produce two isoforms, LAMP-2a and LAMP-2b, respectivel”
Background
Research works printed but not linked: 1
- Lewin, B. Genes VI (Oxford Univ. Press, Oxford, 1997).
Cited by
Items 201–300 of 1,000
Biochemical and Clinical Aspects of Glycogen Storage Diseases
Ellingwood, S. S., & Cheng, A. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0120 · Cited by 118
Proteotoxicity and Cardiac Dysfunction
McLendon, P. M., & Robbins, J. (2015) · Circulation Research · doi:10.1161/circresaha.116.305372 · Cited by 111
Autophagy in neuronal cells: general principles and physiological and pathological functions
Daμμe, M., Suntio, T., Säftig, P., & Eskelinen, E. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1361-4 · Cited by 119
“This is demonstrated by the observations showing that a deficiency of the major lysosomal membrane protein LAMP-2 in mice [226] and man [166] leads to an accumulation of autophagic vacuoles due to an impaired lysosomal/autophagosomal fusion process [53].”
Sanchez, A. M. J., Candau, R. B., Csibi, A., Pagano, A. F., Raibon, A., & Bernardi, H. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00125.2012 · Cited by 116
“This process is constitutively active in skeletal muscle and is enhanced in human myopathies caused by a genetic deficiency of lysosomal proteins, as evidenced by the accumulation of autophagosomes in Pompe’s and Danon’s diseases (89, 100, 121).”
Molecular and cellular basis of genetically inherited skeletal muscle disorders
Dowling, J. J., Weihl, C. C., & Spencer, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00389-z · Cited by 117
Autophagy in Hypertensive Heart Disease
Wang, Z. V., Rothermel, B. A., & Hill, J. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.025023 · Cited by 115
Meléndez, A. (2009) · WormBook · doi:10.1895/wormbook.1.147.1 · Cited by 112
“In mammals, autophagolysosomal fusion involves the integral membrane protein LAMP2 (Gonzalez-Polo et al., 2005; Nishino et al., 2000), and Rab7, a GTP-binding protein (Kimura et al.”
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
Greenberg, B., Taylor, M. R. G., Adler, E. A., Colan, S. D., Ricks, D., Yarabe, P., Battiprolu, P. K., Shah, G., Patel, K., Coggins, M. P., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2412392 · Cited by 112
Autophagic Degeneration and Death of Cardiomyocytes in Heart Failure
Takemura, G., Miyata, S., Kawase, Y., Okada, H., Maruyama, R., & Fujiwara, H. (2006) · Autophagy · doi:10.4161/auto.2608 · Cited by 112
Danon disease: Gender differences in presentation and outcomes
Brambatti, M., Caspi, O., Maolo, A., Koshi, E., Greenberg, B., Taylor, M. R. G., & ADLER, E. D. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.01.020 · Cited by 111
Macroautophagy Signaling and Regulation
Esclatine, A., Chaumorcel, M., & Codogno, P. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-00302-8_2 · Cited by 110
Glycogen storage diseases: Diagnosis, treatment and outcome
Chen, M. A., & Weinstein, D. A. (2016) · Translational Science of Rare Diseases · doi:10.3233/trd-160006 · Cited by 109
Hubert, V., Peschel, A., Langer, B., Gröger, M., Rees, A., & Kain, R. (2016) · Biology Open · doi:10.1242/bio.018648 · Cited by 108
Dexamethasone-induced autophagy mediates muscle atrophy through mitochondrial clearance
Troncoso, R., Paredes, F., Parra, V., Gatica, D., Vásquez-Trincado, C., Quiroga, C., Bravo-Sagua, R., López-Crisosto, C., Rodriguez, A. E., Oyarzún, A. P., et al. (2014) · Cell Cycle · doi:10.4161/cc.29272 · Cited by 108
“So-called autophagic vacuolar myopathies, including Pompe disease and Danon disease, are characterized by the accumulation of autophagosomes in muscle cells.(28,29) Similarly, the “chloroquine myopathy” is marked by the appearance of excessive autophagosomes in response to lysosomal inhibition by the anti-malaria drug…”
BackgroundProtective role of chaperone-mediated autophagy against atherosclerosis
Madrigal-Matute, J., de Bruijn, J., van Kuijk, K., Riascos-Bernal, D. F., Diaz, A., Tasset, I., Martín-Segura, A., Gijbels, M. J. J., Sander, B., Kaushik, S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121133119 · Cited by 107
“To date, the only genetic link between CMA and cardiovascular conditions in humans is with the vacuolar cardiopathy Danon disease, where patients harbor mutations in the LAMP2 gene (63).”
BackgroundAutophagic substrate clearance requires activity of the syntaxin-5 SNARE complex
Renna, M., Schaffner, C., Winslow, A. R., Menzies, F. M., Peden, A. A., Floto, R. A., & Rubinsztein, D. C. (2011) · Journal of Cell Science · doi:10.1242/jcs.076489 · Cited by 107
Review: Danon disease: Review of natural history and recent advances
Cenacchi, G., Papa, V., Pegoraro, V., Marozzo, R., Fanin, M., & Angelini, C. I. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12587 · Cited by 107
Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations
Wen, B., Dai, T., Li, W., Zhao, Y., Liu, S., Zhang, C., Li, H., Wu, J., Li, D., & Yan, C. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.176404 · Cited by 107
“The procedures for protein extraction, measurements of protein concentration and western blot analysis have been described elsewhere.(16) Three controls were normal muscle biopsies of patients who, after all tests were performed, were considered free of muscle diseases.”
MethodThe role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII)
Nascimbeni, A. C., Fanin, M., Masiero, E., Angelini, C., & Sandri, M. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2012.52 · Cited by 106
“…is due to a defect in lysosomal acid α -glucosidase (GAA) 3 , Danon disease is caused by the lack of lysosome-associated membrane protein 2 (Lamp2) 4 and X-linked myopathy with excessive autophagy (XMEA) 5 is triggered by mutations in an essential assembly chaperone of the V-ATPase, the principal…”
Protein Quality Control and Metabolism: Bidirectional Control in the Heart
Wang, Z. V., & Hill, J. A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.016 · Cited by 105
The balance between proinsulin biosynthesis and insulin secretion: where can imbalance lead?
Uchizono, Y., Alarcón, C., Wicksteed, B. L., Marsh, B. J., & Rhodes, C. J. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00774.x · Cited by 91
On the role of autophagy in human diseases: a gender perspective
Lista, P., Straface, E., Brunelleschi, S., Franconi, F., & Malorni, W. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01293.x · Cited by 94
“For example, mice deficient for a member of a family of membrane glycoproteins involved in the protection, maintenance and adhesion of the lysosome, the lysosomal-associated membrane protein 2A, show excessive accumulation of autophagic vacuoles and impaired autophagic degradation of long-lived proteins, resulting in…”
BackgroundWang, Z., Ambrogio, S., Balatti, S., & Ielmini, D. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00438 · Cited by 93
Santin, Y., Sicard, P., Vigneron, F., Guilbeau‐Frugier, C., Dutaur, M., Lairez, O., Couderc, B. C., Manni, D., Korolchuk, V. I., Lezoualc’h, F., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6522 · Cited by 102
“For example, primary deficiency of Lamp2, an essential membrane protein, results in vacuolar cardiomyopathy (Danon disease) in humans and mice deficient in Lamp2 develop a similar phenotype (25).”
Tuning flux: autophagy as a target of heart disease therapy
Xie, M., Morales, C. R., Lavandero, S., & Hill, J. A. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328345980a · Cited by 101
Autophagic Vacuoles with Sarcolemmal Features Delineate Danon Disease and Related Myopathies
Sugie, K., Noguchi, S., Kozuka, Y., Arikawa-Hirasawa, E., Tanaka, M., Yan, C., Saftig, P., von Figura, K., Hirano, M., Ueno, S., et al. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.513 · Cited by 100
Self-citationWang, S.-F., Wu, M.-Y., Cai, C.-Z., Li, M., & Lu, J. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.10.069 · Cited by 101
Mieulet, V., Roceri, M., Espeillac, C., Sotiropoulos, A., Ohanna, M., Oorschot, V., Klumperman, J., Sandri, M., & Pende, M. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00499.2006 · Cited by 99
“In addition, the degradation of long-lived proteins by the formation of autophagic vacuoles accompanies several myopathy diseases (29, 30, 51).”
BackgroundFasting in α1-antitrypsin deficient liver: constitutive activation of autophagy
Teckman, J. H., An, J.-K., Loethen, S., & Perlmutter, D. H. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00041.2002 · Cited by 99
Chapter 21 Monitoring Autophagy in Lysosomal Storage Disorders
Raben, N., Shea, L., Hill, V., & Plotz, P. (2009) · Methods in Enzymology · doi:10.1016/s0076-6879(08)04021-4 · Cited by 97
“Fibroblasts: Subcellular fractionation has been performed in mouse embryonic fibroblasts obtained from LAMP-1 and LAMP-2 double-deficient mice (Eskelinen et al., 2004).”
InfluentialDanon disease – dysregulation of autophagy in a multisystem disorder with cardiomyopathy
Rowland, T. J., Sweet, M. E., Mestroni, L., & Taylor, M. R. G. (2016) · Journal of Cell Science · doi:10.1242/jcs.184770 · Cited by 97
“For reviews discussing other diseases that share clinical similarities with Danon disease, including Pompe disease, Niemann-Pick type C and other lysosomal storage diseases, see Ruivo et al. (2009), D’souza et al. (2014) and Pastores and Hughes (2015).”
BackgroundRole for LAMP-2 in endosomal cholesterol transport
Schneede, A., Schmidt, C. K., Hölttä-Vuori, M., Heeren, J., Willenborg, M., Blanz, J., Domanskyy, M., Breiden, B., Brodesser, S., Landgrebe, J., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00973.x · Cited by 96
“The disease is characterized by the accumulation of late autophagic vacuoles in the heart and skeletal muscle [11, 12].”
BackgroundDanon disease: focusing on heart
Cheng, Z., & Fang, Q. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.72 · Cited by 96
Eat your heart out: Role of autophagy in myocardial ischemia/reperfusion
Gustafsson, Å. B., & Gottlieb, R. A. (2008) · Autophagy · doi:10.4161/auto.5655 · Cited by 95
Ophthalmic Manifestations of Danon Disease
Prall, F. R., Drack, A. V., Taylor, M. R. G., Ku, L., Olson, J. L., Gregory, D. G., Mestroni, L., & Mandava, N. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.030 · Cited by 95
Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice
Petermann, I., Mayer, C., Stypmann, J., Biniossek, M. L., Tobin, D. J., Engelen, M. A., Dandekar, T., Grune, T., Schild, L., Peters, C., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5517fje · Cited by 94
“Adenosine kinase; purine catabolism, inactivates the positive inotrop transmitter adenosine (52) Adk 19527306 2 mo (1.”
BackgroundByrne, S., Dionisi‐Vici, C., Smith, L. J., Gautel, M., & Jungbluth, H. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0399-x · Cited by 94
“The defects implicated in Danon disease [36] and X-linked myopathy with excessive autophagy (MEAX) [37], in particular impaired autolysosomal fusion and defective intralysosomal digestion, concern the same part of the autophagy pathway also affected in Vici syndrome.”
BackgroundFujishima, Y., Nishiumi, S., Masuda, A., Inoue, J., Nguyen, N. M. T., Irino, Y., Komatsu, M., Tanaka, K., Kutsumi, H., Azuma, T., et al. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.12.009 · Cited by 93
Hashem, S. I., Perry, C. N., Bauer, M., Han, S., Clegg, S. D., Ouyang, K., Deacon, D. C., Spinharney, M., Panopoulos, A. D., Izpisua Belmonte, J. C., et al. (2015) · Stem Cells · doi:10.1002/stem.2015 · Cited by 88
“Mutations in LAMP-2 are associated with the X-linked disorder Danon disease [8, 9].”
Insight into the molecular genetics of myopia.
Li, J., & Zhang, Q. (2017) · PubMed Central · Cited by 93
Notomi, S., Ishihara, K., Efstathiou, N. E., Lee, J.-J., Hisatomi, T., Tachibana, T., Konstantinou, E. K., Ueta, T., Murakami, Y., Maidana, D. E., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906643116 · Cited by 92
“Loss-of-function mutations of the human LAMP2 gene cause Danon disease, a lysosomal storage disorder characterized by cardiomyopathy, skeletal myopathy, and mental retardation (29, 30).”
Ryter, S. W., Lee, S.-J., Smith, A., & Choi, A. M. K. (2010) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200909-100js · Cited by 92
“These studies indicate that dysfunctional autophagy can lead to cardiac disease (81, 82).”
BackgroundLysosome-associated membrane proteins-1 and -2 (LAMP-1 and LAMP-2) assemble via distinct modes
Terasawa, K., Tomabechi, Y., Ikeda, M., Ehara, H., Kukimoto‐Niino, M., Wakiyama, M., Podyma‐Inoue, K. A., Rajapakshe, A. R., Watabe, T., Shirouzu, M., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.093 · Cited by 92
Tucker, K. A., Reggiori, F., Dunn, W. A., & Klionsky, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309238200 · Cited by 91
Oral, Ö., Akkoç, Y., Bayraktar, O., & Gözüaçık, D. (2016) · PubMed · doi:10.14670/hh-11-714 · Cited by 90
“Indeed, defective autophagy either by LAMP-2 or ATG5 deficiency in mice was shown to contribute to disease progression (Nishino et al., 2000; Tanaka et al., 2000; Fukuda et al., 2006).”
BackgroundInternational Consensus on Differential Diagnosis and Management of Patients With Danon Disease
Hong, K. N., Eshraghian, E. A., Arad, M., Argirò, A., Brambatti, M., Bui, Q. M., Caspi, O., de Frutos, F., Greenberg, B., Ho, C. Y., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.014 · Cited by 91
Rothaug, M., Stroobants, S., Schweizer, M., Peters, J., Zunke, F., Allerding, M., D’Hooge, R., Saftig, P., & Blanz, J. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0182-y · Cited by 79
“Danon disease patients suffer from severe skeletal and cardiac myopathy as well as intellectual dysfunction [25-27].”
BackgroundInfluentialKhalfan, W., & Klionsky, D. J. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00343-5 · Cited by 90
Vainshtein, A., Grumati, P., Sandri, M., & Bonaldo, P. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1096-z · Cited by 88
“manifest in abnormal delivery of the material sequestered in autophagosomes, including glycogen, to lysosomes for degradation [67].”
BackgroundFanin, M., Nascimbeni, A. C., Fulizio, L., Spinazzi, M., Melacini, P., & Angelini, C. I. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050646 · Cited by 88
Autophagy and Neurodegeneration
Komatsu, M., Kominami, E., & Tanaka, K. (2006) · Autophagy · doi:10.4161/auto.2974 · Cited by 80
Prevalence, pathological mechanisms, and genetic basis of limb‐girdle muscular dystrophies: A review
Taghizadeh, E., Rezaee, M., Barreto, G. E., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27907 · Cited by 87
“Mutations in this gene cause modifications in TRAPP complex composition, Golgi morphology, and cell trafficking (Nishino et al., 2000).”
BackgroundWiessner, M., Roos, A., Munn, C. J., Viswanathan, R., Whyte, T., Cox, D., Schoser, B. G. H., Sewry, C. A., Roper, H., Phadke, R., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.024 · Cited by 86
When intracellular logistics fails - genetic defects in membrane trafficking
Olkkonen, V. M., & Ikonen, E. (2006) · Journal of Cell Science · doi:10.1242/jcs.03303 · Cited by 85
Lysosomal degradation of intracellular nucleic acids—multiple autophagic pathways
Fujiwara, Y., Wada, K., & Kabuta, T. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw085 · Cited by 86
Influence of Normal Aging on Brain Autophagy: A Complex Scenario
Loeffler, D. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00049 · Cited by 76
Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy
Cohen, N., & Muntoni, F. (2004) · Heart · doi:10.1136/hrt.2003.023390 · Cited by 84
Nemoto, T., Tanida, I., Tanida-Miyake, E., Minematsu-Ikeguchi, N., Yokota, M., Ohsumi, M., Ueno, T., & Kominami, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300550200 · Cited by 83
Kim, M., Hunter, R. W., Garcia-Menendez, L., Gong, G., Yang, Y.-Y., Kolwicz, S. C., Xu, J., Sakamoto, K., Wang, W., & Tian, R. (2014) · Circulation Research · doi:10.1161/circresaha.114.302364 · Cited by 83
Autophagy—from molecular mechanisms to clinical relevance
Lippai, M., & Szatmári, Z. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9374-5 · Cited by 83
Impaired autophagy: The collateral damage of lysosomal storage disorders
Myerowitz, R., Puertollano, R., & Raben, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103166 · Cited by 85
“The disease is caused by mutations in the gene on chromosome Xq24 encoding lysosome-associated membrane protein 2 (LAMP-2) [82].”
BackgroundOxidative Stress and Autophagy in Cardiovascular Homeostasis
Morales, C. R., Pedrozo, Z., Lavandero, S., & Hill, J. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5359 · Cited by 83
“In animal models of cardiovascular disease, excessive or insufficient autophagy are each maladaptive, and a wide range of cardiovascular disorders are accompanied by robust increases in the autophagic activity (11, 45, 51, 52, 82).”
Autophagy and mitophagy in the myocardium: therapeutic potential and concerns
Jimenez, R. E., Kubli, D. A., & Gustafsson, Å. B. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12477 · Cited by 76
Muhammad, E., Levitas, A., Singh, S. R., Braiman, A., Ofir, R., Etzion, S., Sheffield, V. C., Etzion, Y., Carrier, L., & Parvari, R. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv423 · Cited by 82
ABCA5 Resides in Lysosomes, and ABCA5 Knockout Mice Develop Lysosomal Disease-Like Symptoms
Kubo, Y., Sekiya, S., Ohigashi, M., Takenaka, C., Tamura, K., Nada, S., Nishi, T., Yamamoto, A., & Yamaguchi, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4138-4149.2005 · Cited by 82
“For example, ABCA1 has been reported to participate in cholesterol trafficking (18, 22), and a genetic defect of it causes Tangier disease, which is characterized clinically by the accumulation of cholesteryl ester in various tissues (9).”
BackgroundSelf-citationWu, G., Wang, X., Feng, X., Zhang, A., Li, J., Gu, K., Huang, J. A., Pang, S., Dong, H., Gao, H., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.013 · Cited by 83
Trivedi, P. C., Bartlett, J. J., Perez, L. J., Brunt, K. R., Legare, J. F., Hassan, A., Kienesberger, P. C., & Pulinilkunnil, T. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.004 · Cited by 81
Impaired mitophagy facilitates mitochondrial damage in Danon disease
Hashem, S. I., Murphy, A. N., Divakaruni, A. S., Klos, M., Nelson, B., Gault, E. C., Rowland, T. J., Perry, C. N., Gu, Y., Dalton, N. D., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.05.007 · Cited by 81
Proteasome dysfunction induces muscle growth defects and protein aggregation
Kitajima, Y., Tashiro, Y., Suzuki, N., Warita, H., Kato, M., Tateyama, M., Ando, R., Izumi, R., Yamazaki, M., Abe, M., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.150961 · Cited by 79
“…of autophagy is involved in the pathogenic mechanisms of several myopathies, such as Pompe disease (Raben et al., 2008), Danon disease (Nishino et al., 2000), VMA21 deficiency (Ramachandran et al., 2013), autosomal dominant inclusion body myopathy associated with Paget’s disease of…”
BackgroundAutophagy dysregulation in Danon disease
Nascimbeni, A. C., Fanin, M., Angelini, C., & Sandri, M. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.475 · Cited by 79
“DD is an X-linked dominant disorder caused by the deficiency of lysosome-associated membrane protein 2 (LAMP2).(4) DD patients typically show hypertrophic cardiomyopathy, muscle weakness and mental retardation.”
BackgroundSignaling and other functions of lipids in autophagy: a review
Soto-Avellaneda, A., & Morrison, B. E. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01389-2 · Cited by 79
“However, studies in which the Lamp2 gene is deleted in mice result in a Danon’s disease-like phenotype and accumulation of autophagosomes [23].”
InfluentialAutophagy in aging and in neurodegenerative disorders
Rajawat, Y. S., & Bossis, I. (2008) · HORMONES · doi:10.14310/horm.2002.1111037 · Cited by 79
Lee, H. S., Daniels, B. H., Salas, E., Bollen, A. W., Debnath, J., & Margeta, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036221 · Cited by 78
“, all of which are characterized by accumulation of autophagic vacuoles. While pathogenesis of these disorders is still being elucidated, the overarching defect seems to involve lysosomal function. For example, Danon disease mutations involve the gene encoding lysosome-associated membrane protein 2 (LAMP2), a protein…”
BackgroundSudhakar, J. N., Lu, H.-H., Chiang, H.-Y., Suen, C., Hwang, M., Wu, S., Shen, C., Chang, Y., Li, F., Liu, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18102-7 · Cited by 78
Patergnani, S., Missiroli, S., Morciano, G., Perrone, M., Mantovani, C. M., Anania, G., Fiorica, F., Pinton, P., & Giorgi, C. (2021) · Cancers · doi:10.3390/cancers13225622 · Cited by 77
“For example, genetic deficiency in LAMP2 causes cardiomyopathy known as Danon’s disease [91].”
BackgroundNovel Therapies for Prevention and Early Treatment of Cardiomyopathies: Now and in the Future
Repetti, G. G., Toepfer, C. N., Seidman, J. G., & Seidman, C. E. (2019) · Circulation Research · doi:10.1161/circresaha.119.313569 · Cited by 78
“in autophagy may promote cell death, whereas premature glycogen accumulation may alter cardiac metabolism.(103,107,110)”
BackgroundAAV-mediated in vivo functional selection of tissue-protective factors against ischaemia
Ruozi, G., Bortolotti, F., Falcione, A., Dal Ferro, M., Ukovich, L., Macedo, A., Zentilin, L., Filigheddu, N., Cappellari, G. G., Baldini, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms8388 · Cited by 76
Autophagy in Lysosomal Myopathies
Malicdan, M. C. V., & Nishino, I. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00543.x · Cited by 75
Self-citationMacroautophagy and Chaperone‐Mediated Autophagy in Heart Failure: The Known and the Unknown
Ghosh, R., & Pattison, J. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8602041 · Cited by 75
“Mutations in the lysosomal LAMP2 gene causes Danon disease which is inherited in an X-linked dominant fashion, eventually developing a hypertrophic cardiomyopathy [202, 203].”
BackgroundPattingre, S., Vries, L. D., Bauvy, C., Chantret, I., Cluzeaud, F., Ogier‐Denis, É., Vandewalle, A., & Codogno, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300917200 · Cited by 75
Molecular regulation of autophagy and its implications for metabolic diseases
Ryter, S. W., Koo, J. K., & Choi, A. M. K. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000068 · Cited by 74
“Several inherited myopathies are associated with aberrant autophagy [16,17].”
BackgroundKaushik, S., & Cuervo, A. M. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.002 · Cited by 74
Danon disease presenting with dilated cardiomyopathy and a complex phenotype
on behalf of the Familial Cardiomyopathy Registry, Taylor, M. R. G., Ku, L., Slavov, D. B., Cavanaugh, J. L., Boucek, M. M., Zhu, X., Graw, S. L., Carniel, E., Barnes, C., et al. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0184-8 · Cited by 74
“The mutation obliterates the carboxy sequences for both the lysosomal transmembrane and lysosomal targeting domains, predicting that the protein, if produced, would be unable to target to the lysosome or integrate into the lysosomal membrane (Nishino et al. 2000) Native LAMP-2 protein was absent by Western blotting in…”
BackgroundMethodInfluentialCardiomyocyte autophagy and cancer chemotherapy
Li, D. ‘., & Hill, J. A. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.007 · Cited by 73
“Disruption of autophagosome turnover has been observed in various human diseases, including Danon cardiomyopathy [18,19].”
Sudden Death Associated With Danon Disease in Women
Miani, D., Taylor, M. R. G., Mestroni, L., D’Aurizio, F., Finato, N., Fanin, M., Brigido, S., & Proclemer, A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.09.024 · Cited by 73
Molecular control of chaperone-mediated autophagy
Catarino, S., Pereira, P., & Girão, H. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170057 · Cited by 73
Lee, J., Ishihara, K., Notomi, S., Efstathiou, N. E., Ueta, T., Maidana, D. E., Chen, X., Iesato, Y., Caligiana, A., & Vavvas, D. G. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.138 · Cited by 75
Disorders of Carbohydrate Metabolism
Kishnani, P. S., & Chen, Y.-T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05565-3 · Cited by 72
Maintenance of sarcomeric integrity in adult muscle cells crucially depends on Z-disc anchored titin
Swist, S., Unger, A., Li, Y., Vöge, A., von Frieling-Salewsky, M., Skärlén, Å., Cacciani, N., Braun, T. W., Larsson, L., & Linke, W. A. (2020) · Nature Communications · doi:10.1038/s41467-020-18131-2 · Cited by 71
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion
Duguez, S., Duddy, W. J., Johnston, H., Lainé, J., Bihan, M. L., Brown, K. J., Bigot, A., Hathout, Y., Butler-Browne, G. S., & Partridge, T. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1248-2 · Cited by 70
“It is noteworthy in this respect that dystrophin has been detected in lysosomal membranes in vacuolar myopathies caused by LAMP2 deficiency [39–41] and in colchicine induced myopathy [42], both characterized by accumulation within myofibers of dystrophin positive vacuoles.”
BackgroundRbfox Splicing Factors Maintain Skeletal Muscle Mass by Regulating Calpain3 and Proteostasis
Singh, R. K., Kolonin, A. M., Fiorotto, M. L., & Cooper, T. A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.017 · Cited by 70
Role of autophagy in muscle disease
Franco‐Romero, A., & Sandri, M. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101041 · Cited by 71
Cardiomyocyte health: adapting to metabolic changes through autophagy
Kubli, D. A., & Gustafsson, Å. B. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.11.004 · Cited by 71
“The heart utilizes autophagy to maintain cellular homeostasis under both baseline conditions and in response to stress [1-4].”
BackgroundLandstrom, A. P., Adekola, B. A., Bos, J. M., Ommen, S. R., & Ackerman, M. J. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.08.001 · Cited by 69
Interplay between the ubiquitin-proteasome system and autophagy in proteinopathies.
Zheng, Q., Li, J., & Wang, X. (2009) · Europe PMC (PubMed Central) · Cited by 70
The LAMP‐like protein p67 plays an essential role in the lysosome of African trypanosomes
Peck, R. F., Shiflett, A. M., Schwartz, K. J., McCann, A., Hajduk, S. L., & Bangs, J. D. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06195.x · Cited by 69
“However, LAMP-2 deficiency causes the human genetic cardiac disorder Danon Disease (Nishino et al., 2000; Saftig et al., 2001), and LAMP-2 knockout mice display a severe phenotype with increased early mortality and accumulation of autophagic vacuoles (Tanaka et al.”
BackgroundApelin-13 promotes cardiomyocyte hypertrophy via PI3K-Akt-ERK1/2-p70S6K and PI3K-induced autophagy
Xie, F., Liu, W., Feng, F., Li, X., He, L., Lv, D., Qin, X., Li, L., Li, L., & Chen, L. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv111 · Cited by 69
Activation of Autophagy Ameliorates Cardiomyopathy in Mybpc3 -Targeted Knockin Mice
Singh, S. R., Zech, A. T. L., Geertz, B., Reischmann, S., Osińska, H. E., Prondzynski, M., Krämer, E., Meng, Q., Redwood, C. S., van der Velden, J., et al. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004140 · Cited by 69
Yamaguchi, O. (2019) · Circulation Journal · doi:10.1253/circj.cj-18-1065 · Cited by 69
Gómez, R., Cowling, B. S., & Laporte, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111377 · Cited by 68
Metadata
- Authors
- Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., Sue, C. M., Yamamoto, A., Murakami, N., Shanske, S., Byrne, E., Bonilla, E., Nonaka, I., DiMauro, S., & Hirano, M.
- Affiliations
- Columbia University (US)
- Kyushu University (JP)
- St. Marianna University School of Medicine (JP)
- Yokohama Rosai Hospital (JP)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- West Virginia University (US)
- University of Alabama at Birmingham (US)
- Kurume University (JP)
- National Center of Neurology and Psychiatry (JP)
- St Vincent's Hospital Melbourne (AU)
- Corresponding author
- Nishino, Ichizo
- ORCID
- Venue
- Nature
- Published
- 2000-08
- Volume
- 406
- Issue
- 6798
- Pages
- 906-910
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2109716633
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 30 · 2023: 44 · 2022: 35 · 2021: 44 · 2020: 45 · 2019: 46 · 2018: 57 · 2017: 45 · 2016: 62 · 2015: 44 · 2014: 40 · 2013: 51 · 2012: 45
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Danon disease, lysosomal membrane proteins, lysosomal storage disease, cardiomyopathy, myopathy, intracytoplasmic vacuoles, glycogen storage disease
- MeSH terms
- DNA Mutational Analysis, Female, Humans, Immunohistochemistry, Genetic Linkage, Male, Membrane Glycoproteins, Molecular Sequence Data, Muscular Diseases, Cardiomyopathies, Vacuoles, X Chromosome, Blotting, Western, Antigens, CD, Lysosomal Storage Diseases, Sequence Analysis, DNA, Muscle, Skeletal, Lysosomal Membrane Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.